Oral desmopressin has also been shown to be an effective treatment for central diabetes insipidus, and can be useful in patients with mucosal atrophy or scarring. Most patients require an oral ...

Monitor laboratory tests for patients with central diabetes insipidus or postsurgical or head trauma-related polyuria and polydipsia, including urine volume and osmolality. There have been no ...

Most times, it's a problem in the brain that leads to a deficiency of ADH and causes diabetes insipidus. In these cases, the condition is referred to as central diabetes insipidus. With central ...

Eton Pharmaceuticals, Inc. announced positive results from its pivotal bioequivalence study of ET-600, a patented oral solution of desmopressin aimed at treating central diabetes insipidus.

ET-600 is a proprietary formulation of desmopressin oral solution developed for the treatment of central diabetes insipidus. The company has been issued a patent for ET-600’s formulation that extends ...

A drug acting to interfere with free-water formation would be of therapeutic value to the patient with diabetes insipidus, particularly the nephrogenic sort, if attendant losses of electrolyte in ...

After clinical and neuroradiological investigation patients were classified into : idiopathic (n=23), DI with central lesion ... hypothyroidism, Type I diabetes and thyroiditis).

Absence of anti-rabphilin-3A antibodies in children and young adults with idiopathic central diabetes insipidus: a potential clue to elucidating a tumor etiology. Differences in segmental hair ...

Claim your 7-day free trial now. Central diabetes insipidus (CDI), or arginine vasopressin deficiency, is a condition where the body doesn’t produce enough antidiuretic hormone (ADH ...